Back to results

RecruitingPhase 1

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

NCT06657768

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Collaborative Neuroscience Network - CNS

Los Alamitos, California, United States

+12 additional locations

Contact

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

1-317-615-4559 LillyTrials@Lilly.com

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2024-10-29
Enrollment: 128 participants
Sponsor: Eli Lilly and Company
Purpose: basic science

Locations (13)

Collaborative Neuroscience Network - CNSLos Alamitos, California, United States
K2 Medical Research - The VillagesLady Lake, Florida, United States
K2 Medical ResearchMaitland, Florida, United States
Aqualane Clinical ResearchNaples, Florida, United States
Progressive Medical ResearchPort Orange, Florida, United States
K2 Medical Research - TampaTampa, Florida, United States
Atlanta Center of Medical ResearchAtlanta, Georgia, United States
CenExel iResearch, LLC (CenExel iRA)Decatur, Georgia, United States
QUEST Research InstituteFarmington Hills, Michigan, United States
CenExel-HRIMarlton, New Jersey, United States
Duke Early Phase Research UnitDurham, North Carolina, United States
The University of Tokyo HospitalBunkyō City, Japan
National Center for Geriatrics and GerontologyŌbu, Japan